Macular retinal thickness differs markedly in age-related macular degeneration driven by risk polymorphisms on chromosomes 1 and 10

• Published in: Scientific reports 2020-12, Vol.10 (1), p.21093-21093, Article 21093
• Main Authors: Zouache, Moussa A., Bennion, Alex, Hageman, Jill L., Pappas, Christian, Richards, Burt T., Hageman, Gregory S.
• Format: Article
• Language: English
• Subjects: 631/208/2489/144; 692/308/2056; 692/420/2489; 692/699/3161/1626; Age; Aged; Aged, 80 and over; Chromosome 1; Chromosome 10; Chromosomes; Chromosomes, Human, Pair 1 - genetics; Chromosomes, Human, Pair 10 - genetics; Complement Factor H - genetics; Complement System Proteins - genetics; Eye; Female; Haplotypes; High-Temperature Requirement A Serine Peptidase 1 - genetics; Humanities and Social Sciences; Humans; Macular degeneration; Macular Degeneration - diagnostic imaging; Macular Degeneration - genetics; Male; Middle Aged; multidisciplinary; Polymorphism, Single Nucleotide; Proteins - genetics; Retina; Retina - diagnostic imaging; Science; Science (multidisciplinary)
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-78059-x

The two most common genetic contributors to age-related macular degeneration (AMD), a leading cause of irreversible vision loss worldwide, are variants associated with CFH-CFHR5 on chromosome 1 (Chr1) and ARMS2 / HTRA1 on chromosome 10 (Chr10). We sought to determine if risk and protective variants associated with these two loci drive differences in macular retinal thickness prior and subsequent to the onset of clinically observable signs of AMD. We considered 299 individuals (547 eyes) homozygous for risk variants or haplotypes on Chr1 or Chr10 exclusively ( Chr1-risk and Chr10-risk , respectively) or homozygous for a neutral haplotype ( Chr1-neu) , for the protective I62 tagged haplotype ( Chr1-prot-I62) or for the protection conferring CFHR3/1 deletion haplotype ( Chr1-prot-del) on Chr1 without any risk alleles on Chr10. Among eyes with no clinically observable signs of AMD, the deletion of CFHR3/1 , which is strongly protective against this disease, is associated with significantly thicker retinas in the perifovea. When controlling for age, Chr10-risk eyes with early or intermediate AMD have thinner retinas as compared to eyes from the Chr1-risk group with similar disease severity. Our analysis indicates that this difference likely results from distinct biological and disease initiation and progression events associated with Chr1- and Chr10-directed AMD.